Compounds structurally related to tamoxifen as openers of large-conductance calcium-activated K+ channel

Chemical and Pharmaceutical Bulletin

Volumn 53, Issue 10, 2005, Pages 1372-1373

  Sha, Yu ^a,b   Tashima, Toshihiko ^a   Mochizuki, Yumi ^a   Toriumi, Yoshimi ^a   Adachi Akahane, Satomi ^a   Nonomura, Taro ^a   Cheng, Maosheng ^b   Ohwada, Tomohiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

(xeno)estrogen; Channel opener; Electrophysiology; Large conductance calcium activated K+ channel; Tamoxifen

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; TAMOXIFEN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; EMBRYO; HUMAN; HUMAN CELL;

COLORING AGENTS; DRUG DESIGN; MOLECULAR STRUCTURE; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; TAMOXIFEN;

EID: 26444464328     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.53.1372     Document Type: Article

References (22)

1. Gribkoff V. K., Starrett J. E., Jr., Droretzky S. I., "Advances in Pharmacology," Vol. 37, ed. by Augst J. T., Anders M. W., Murad F., Coyle J. T., Academic Press, San Diego, 1997, pp. 319-349.
2. Niu X., Magleby K. L., Proc. Natl. Acad. Sci. U.S.A., 99, 11441-11446 (2002).
3. Jiang Y., Lee A., Chen J., Cadene M., Chalt B. T., MacKinnon R., Nature (London), 417, 515-522 (2002).
4. Garica-Calvo M., Knaus H.-G., McManus O. B., Giangiacomo K. M., Kaczorowski G. J., Garcia M. L., J. Biol. Chem., 269, 676-682 (1994).
5. Tian L., Duncan R. R., Hammond M. S., Coghill L. S., Wen H., Rusinova R., Clark A. G., Levitan I. B., Shipston M. J., J. Biol. Chem., 276, 7717-7720 (2001).
6. Zarei M. M., Eghbali M., Alioua A., Song M., Knaus H. G., Stefani E., Toro L., Proc. Natl. Acad. Sci. U.S.A., 101, 10072-10077 (2004).
7. Knaus H.-G., Folander K., Garcia-Calvo M., Garcia M. L., Kaczorowski G. J., Smith M., Swanson R., J. Biol. Chem., 269, 17274-17278 (1994).
8. Tanaka Y., Koike K., Alioua A., Shigenobu K., Stefani E., Taro L., J. Pharmacol. Sci., 94, 339-347 (2004).
9. Tseng-Crank J., Godinot N., Johansen T. E., Ahring P. K., Støbæk D., Mertz R., Foster C. D., Olesen S.-P., Reinhart P. H., Proc. Natl. Acad. Sci. U.S.A., 93, 9200-9205 (1996).
10. Knaus H.-G., Schwarzer C., Koch R. O. A., Eberhart A., Kaczorowski G. J., Glossmann H., Wunder F., Pongs O., Garcia M. L., Sperk G., J. Neurosci., 16, 955-963 (1996).
11. Sah P., Faber E. S. L., Prog. Neurobio., 66, 345-353 (2002).
12. Coghlan M. J., Carroll W. A., Gopalakrishnan M., J. Med. Chem., 44, 1627-1653 (2001).
13. Shieh C.-C., Coghlan M., Sullivan J. P., Gopalakrishnan M., Pharmacol. Rev., 52, 557-593 (2000).
14. Gribkoff V. K., Starrett J. E., Jr., Dworetzky S. I., Hewawasam P., Boissard C. G. J. R., Huston K., Johnson G., Krishman B. S., Kinney G. G., Lombardo L. A., Meanwell N. A., Molinoff P. B., Myers R. A., Moon S. L., Ortiz A., Pajor L., Pieschl R. L., Post-Munson D. J., Signor L. J., Srinivas N., Taber M. T., Thalody G., Trojnacki J. T., Wiener H., Yeleswarm K., Yeola S. W., Nature Medicine, 7, 471-477 (2001).
15. Tamoxifen derivatives: Valverde M. A., Rojas P., Amigo J., Cosmelli D., Orio P., Bahamonde M. I., Mann G. E., Vergara C., Latorre R., Science, 285, 1929-1931 (1999).
16. Tamoxifen derivatives: Dick G. M., Rossow C. F., Smirnov S., Horowitz B., Sanders K. M., J. Biol. Chem., 276, 34594-34599 (2001).
17. Tamoxifen derivatives: Dick G. M., Sanders K. M., J. Biol. Chem., 276, 44835-44840 (2001).
18. Tamoxifen derivatives: Dick G. M., Hunter A. C., Sanders K. M., Mol. Pharmacol., 61, 1105-1113 (2002).
19. Dunncan R. K., Biochem. Pharmacol., 70, 47-58 (2005).
20. McMurry coupling: Detsi A., Koufaki M., Calogeropoulou T., J. Org. Chem., 67, 4608-4611 (2002).
21. Yamada A., Gaja N., Ohya S., Muraki K., Narita H., Ohwada T., Imaizumi Y., Jpn. J. Pharmacol., 86, 342-350 (2001).
22. Nishimaru K., Eghbali M., Lu R., Marijic J., Stefani E., Toro L., J. Physiol., 559, 849-862 (2004).